A Study of JSKN027 in Patients With Advanced Solid Tumors

NCT07391644 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG: JSKN027

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd